← hubDrugs

Adinazolam

Discover related

3 sources

← All substances
🔗 MergedCompareTripSitPharmacologyDrugCentral

Collated from TripSit, Pharmacology, DrugCentral. Where sources differ (e.g. dosing), Compare shows them side by side.

Sections

Also known as deracynTS

Benzodiazepine derivative that has some antidepressant properties. Never FDA approved, yet however has been sold as a research chemical.TS

Oral

Route dataTripSit

ThresholdLightCommonStrongHeavy
5–15 mg15–30 mg30–50 mg—+
050 mg
LightCommonStrongHeavy
Onset10–25 minutes
Total2–5 hours
After-effects1–16 hours
OnsetCome-upPeakOffset

🧬 Receptor activityDC

TargetActionAffinitySource
GABA-A receptor (GABRD)Positive allosteric modulatorDRUGCENTRAL
Translocator protein (TSPO)7.1 IC50DRUGCENTRAL
‹ PrevPage 1 / 11–2 of 2Next ›

Mechanism of actionPH

Adinazolam binds to peripheral-type benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways.

PharmacodynamicsPH

Adinazolam is a benzodiazepine derivative used to treat anxiety, status epilepticus, and for sedation induction and anterograde amnesia. Adinazolam binds with high affinity to the GABA benzodiazepine receptor complex. Considerable evidence suggest that the central pharmacologic/therapeutic actions of alprazolam are mediated via interaction with this receptor complex.

Pharmacokinetics

Half-lifePH

Less than 3 hours.

MetabolismPH

The drug primarily undergoes hepatic metabolism to form the main metabolite N-desmethyladinazolam, alpha-hydroxyalprazolam, and estazolam.
Adinazolam has known human metabolites that include N-demethyladinazolam.

Plan when to take Adinazolam — see where onset, peak and comedown land on the clock

Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.